← Leaderboards
Joseph T Flynn
University Of Michigan At Ann Arbor
$197,814
Attributed
$197,814
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$197,814 · 3
By mechanism
M01$197,814 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Matthias Kretzler$40,447,062
- Benjamin L Margolis$9,338,343
- Michael J Imperiale$14,421,971
- Paul B Watkins$20,798,906
- Yan Sun$7,090,899
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectChild (0-11)Clinical ResearchNutrition Related TagYoung Adult Human (21-34)Clinical TrialsHormone TherapyHuman Therapy EvaluationIga NephropathyPostoperative StatePrednisoneRecombinant ProteinsSomatotropinTocopherolsUrinalysisVitamin TherapyKidney TransplantationDietary SupplementsDiet TherapyDrug Adverse EffectKidney FunctionBlood ChemistryLongitudinal Human StudyMarine Animal Oil
Grant awards (6)
NUTROPIN RECOMBINANT HUMAN GROWTH HORMONE IN POST RENAL TRANSPLANTATION$197,196
M01 · FY2002 · RR
PREDNISONE &FISH OIL SUPPLEMENTS IN CHILDREN &YOUNG ADULTS W/ IGA NEPHROLOGY$0
M01 · FY2002 · RR
VITAMIN E IN TREATMENT OF IGA NEPHROPATHY IN CHILDREN$0
M01 · FY2002 · RR
NUTROPIN RECOMBINANT HUMAN GROWTH HORMONE IN POST RENAL TRANSPLANTATION$206
M01 · FY2000 · RR
PREDNISONE &FISH OIL SUPPLEMENTS IN CHILDREN &YOUNG ADULTS W/ IGA NEPHROLOGY$206
M01 · FY2000 · RR
VITAMIN E IN TREATMENT OF IGA NEPHROPATHY IN CHILDREN$206
M01 · FY2000 · RR